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Edited by Felix WielandAbstract Pleurotus ostrearus proteinase A inhibitor 1
(POIA1), which was discovered as a protease inhibitor, is unique
in that it shows sequence homology to the propeptide of subtili-
sin, which functions as an intramolecular of a cognate protease.
In this study, we demonstrate that POIA1 can function as an
intramolecular chaperone of subtilisin by in vitro and in vivo
experiments. The speciﬁc cleavage between POIA1 and the ma-
ture region of subtilisin BPN 0 occurred in a refolding process of a
chimera protein, and Bacillus cells transformed with a chimera
gene formed a halo on a skim milk plate. The mutational analy-
ses of POIA1 in the chimera protein suggested that the tertiary
structure of POIA1 is required for such a function, and that an
increase in its ability to bind to subtilisin BPN 0 makes POIA1 a
more eﬀective intramolecular chaperone.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The three-dimensional structures of proteins are generally
determined by their primary structures and therefore basically
refold spontaneously from a denatured state. However, there
are many proteins that require molecular chaperones for the
correct folding of their tertiary and quaternary structures.
The propeptides of proteases are unique among various molec-
ular chaperones, because they are degraded by a cognate
protease after the single-turnover catalysis of protease folding
[1–3]. Many propeptides are located between a signal peptide
and the mature regions of the precursor forms of proteases,
and therefore named ‘‘intramolecular chaperones’’ [1]. The
propeptides of subtilisins have been most extensively studied.
Although they lack three-dimensional structures in isolated
form, they acquire a tertiary structure by forming a complex
with their cognate protease [4–6]. They also function as prote-
ase inhibitors by binding to the substrate-binding pocket of
proteases using their C-terminal region [7–9]. Attempts to
introduce the tertiary structure into the isolated form of the
propeptide of subtilisin BPN 0 by amino acid substitutions byAbbreviation: POIA1, Pleurotus ostrearus proteinase A inhibitor 1
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doi:10.1016/j.febslet.2005.06.083Bryans [10,11,13,14] and our groups [12] have been successful.
Moreover, the close relationships between tertiary structure
formation and increases in activities as a molecular chaperone
and a protease inhibitor have been reported [10–15].
Pleurotus ostreatus proteinase A inhibitor 1 (POIA1) and
yeast proteinase B inhibitor 2 are proteins that were isolated
as protease inhibitors composed of about 70 residues excluding
Cys residues [16,17] and showing amino acid sequence homol-
ogies of approximately 30% to the propeptides of subtilisins.
Our mutational analyses suggested that they are unique prote-
ase inhibitors that utilize their C-terminal regions as reactive
sites [18,19]. Although their wild-type proteins function as
digestible temporary inhibitors when subtilisin BPN 0 was used
as a target protease, mutated proteins whose C-terminal six
residues had been replaced by those of the propeptide of sub-
tilisin BPN 0 were converted into stronger and resistant inhibi-
tors. In the C-terminal region, the C-terminal residue was
considered the most important in binding to the P1 pocket
of subtilisin BPN 0. Recently, we have determined the three-
dimensional structure of wild-type POIA1 by NMR, and
found that it is structurally very similar to the propeptide of
subtilisin BPN in the complex with subtilisin BPN [20]. On
the basis of these ﬁndings, in this study, we determined
whether POIA1 can function as an intramolecular chaperone
by in vitro and in vivo experiments. Through this study, we
may shed light into the molecular mechanisms of propeptide-
mediated refolding of subtilisin from diﬀerent viewpoints.2. Materials and methods
2.1. Construction of expression plasmid in Escherichia coli of
pro-subtilisin BPN 0 or chimera protein of POIA1 and subtilisin
BPN 0 with Ser221ﬁ Cys substitution
The propeptide-encoding region of the wild-type subtilisin BPN0
gene was initially substituted with a mutated POIA1 (POIA1cm) gene
in which the C-terminal six residues had been substituted with those of
the propeptide of subtilisin BPN 0. The plasmid pSUB-N encoding the
N-terminal half of prepro-subtilisin BPN 0 [21] was digested with EcoRI
and SplI to remove the promoter- and propeptide-encoding regions of
subtilisin BPN 0. A truncated POIA1 gene lacking the region corre-
sponding to Gly61-Gln76 was obtained by digesting the POIA1-encod-
ing plasmid [19] with EcoRI and PstI. Then, the synthetic
oligonucleotides encoding Gly61-Tyr76 of POIA1cm were ligated with
the two fragments described above. Thus constructed plasmid pPOcm-
SubN encodes the mutated chimera protein of POIA1cm and the
N-terminal half of mature subtilisin BPN 0.
To construct the expression plasmid of wild-type POIA1-subtilisin
BPN 0 chimera protein, the plasmid pPOcmSubN was digested with
PstI and SplI to remove the region corresponding to the C-terminal re-
gion of POIA1cm, and the annealed synthetic oligonucleotides encod-
ing Gly61-Gln76 of the wild-type POIA1 were inserted into this site.blished by Elsevier B.V. All rights reserved.
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CCCAGG using Quik Change Mutagenesis Kit to produce a plasmid
pPOSubN. To change the processing site -Ala-Gln-AlaﬂAla-Gly- be-
tween the signal peptide and the propeptide region of wild-type subtil-
isin BPN 0 to -Ala-Gln-AlaﬂMet-Ala-Gly-, the NcoI–ClaI fragment of
pTVSubN encoding the N-terminal half of pro-subtilisin starting with
Met [15] was inserted into the NcoI–ClaI site of pPOcmSubN. Thus
constructed plasmid was named pProSubN. Construction of a mutated
subtilisin gene which possesses a signal peptide and a mature region
but lacks a propeptide region of subtilisin BPN 0 was carried out by
deletion mutagenesis using Quik Change Mutagenesis Kit using
pSUB-N as a template. The partial amino acid sequences around the
processing sites of proteins encoded in the plasmids thus constructed
are summarized in Fig. 1.
Then, the EcoRI–HindIII fragment of pSUB-C encoding the C-ter-
minal half of subtilisin BPN 0 [21] was inserted into the EcoRI–HindIII
site of pTZ19U, and the substitution of Ser221 with Cys was carried
out by Kunkels method [22]. A mutated subtilisin BPN 0 gene was
obtained by digesting a mutated plasmid with ClaI and BglII, and in-
serted into the NcoI–BamHI site of pET11d, along with the NcoI–ClaI
fragment encoding wild-type-like pro-subtilisin BPN 0 or the chimera
protein in which wild-type or mutated POIA1 was fused to the N-ter-
minus of subtilisin BPN 0 to construct an expression plasmid in E. coli.
2.2. Expression in E. coli and puriﬁcation of pro-subtilisin or chimera
protein
The expression plasmid of pro-subtilisin or chimera protein with a
Ser221ﬁ Cys substitution in subtilisin BPN 0 constructed in pET11d
was transferred into E. coli BL21(DE3). The subsequent cultivation
of E. coli, and the expression and puriﬁcation of either protein under
denaturing conditions were carried out essentially as described previ-
ously [15] with modiﬁcation, that is, the chimera proteins of POIA1
with subtilisin were puriﬁed using DEAE-cellulose.
2.3. In vitro refolding of pro-subtilisin or chimera protein of POIA1 and
subtilisin
The concentration of puriﬁed pro-subtilisin or the chimera proteins
in 6 M urea/50 mM Tris–HCl (pH 7.0) was determined from their
absorbance at 280 nm with molar coeﬃcient constants of
34990 M1 cm1 for pro-subtilisin, 32490 M1 cm1 for POIA1cm-
subtilisin and its Pheﬁ Ala mutants and 31240 M1 cm1 for
POIA1-subtilisin [4,23], and then adjusted to 10 lM.
The protein solutions thus obtained were dialyzed against 50 mM
Tris–HCl/0.5 M (NH4)2SO4/1 mM CaCl2/5 mM 2-mercaptoethanol
(pH 7.0) at 4 C for 2 days. After the dialysis, proteins were precipi-
tated by adding trichloroacetic acid to a ﬁnal concentration of 20%
and subjected to SDS–polyacrylamide gel electrophoresis.
2.4. Expression of subtilisin BPN 0 or chimera protein gene in
Bacillus subtilis
A fragment encoding the promoter region and signal peptide of sub-
tilisin BPN0 obtained by amplifying the subtilisin BPN 0 gene through
PCR was digested with DraI and NcoI and inserted into the SmaI–ClaI
site of pSUB-N along with the NcoI–ClaI fragment obtained by digest-
ing the plasmid pPOSubN, pPOcmSubN or pProSubN. Then, the chi-
mera gene thus constructed was digested with EcoRI and ClaI, and
inserted into the EcoRI–HindIII site of the E. coli–B. subtilis shuttleFig. 1. Junction sequences between signal peptide, propeptide or POIA1 and
fused protein of POIA1 and subtilisin BPN 0, and that between signal peptide
BPN 0 constructed in this study. To make the junction sequence uniform,
subtilisin BPN 0 was changed to produce wild-type-like subtilisin BPN 0.vector pHY300PLK [24] along with the ClaI–HindIII fragment encod-
ing the C-terminal half of subtilisin BPN 0 to obtain the expression
plasmid of the chimera protein in B. subtilis. Then, the expression plas-
mid was converted into multimerized form by the recA+ strain of
E. coli, and then introduced into B. subtilis UOT0999 using tetracyclin
as a selection marker. Transformants were transferred onto an LB
plate containing 1% skim milk and incubated at 37 C for 39 h. For
protein analysis, the transformants were inoculated and incubated in
50 ml of LB medium at 37 C for 2 days, and proteins in the cul-
ture supernatants were precipitated by adding trichloroacetic acid to
a ﬁnal concentration of 20% and subjected to SDS–polyacrylamide
gel electrophoresis.
2.5. Measurements of proteolytic activity
Proteolytic activity in the supernatants of 50 ml culture of Bacillus
cells incubated for 2 days was measured at 25 C using 0.1 mM N-suc-
cinyl-Ala-Ala-Pro-Phe p-nitroanilide in 0.1 M Tris–HCl (pH 8.6) by
monitoring increase of the absorbance at 410 nm.
2.6. Site-directed mutagenesis
The substitution of Phe at position 44 or 56 of POIA1cm in the chi-
mera protein with subtilisin BPN 0 was carried out using the Quik
Change Mutagenesis Kit with pPOcmSubN as a template and muta-
tion primers designed to replace the Phe codon (TTC) with the Ala co-
don (GCC). The expression plasmid in E. coli or B. subtilis from
pPOcmSubN was constructed as described above.3. Results
3.1. In vitro experiments: subtilisin refolding and processing by
chimera proteins
To determine the possibility of POIA1 functioning as an
intramolecular chaperone of subtilisin BPN 0 in vitro, wild-type
or mutated POIA1 (POIA1cm) whose C-terminal six residues
had been substituted with those of the propeptide of subtilisin
BPN 0 was fused to the N-terminus of mature subtilisin BPN 0 in
which catalytic Ser221 was substituted with Cys, and the chi-
mera proteins thus constructed were expressed in E. coli. Since
pro-subtilisin BPN 0 with Cys as a catalytic residue has been
shown to be speciﬁcally cleaved at only the junction site be-
tween the propeptide and mature regions without resulting in
the subsequent autodegradation of the propeptide [4], the
POIA1-mediated refolding of subtilisin BPN 0 was investigated
on the basis of the occurrence of this processing, making the
conclusion more simple than the case in which autodegrada-
tion of subtilisin BPN 0 would occur by the presence of catalytic
Ser221. Because the mutational analyses of the propeptide of
subtilisin BPN 0 have shown that its intramolecular chaperone
activity is closely related to its ability to bind to a cognate
protease [10–15] and our previous study has demonstrated that
the substitution of C-terminal six residues with those of themature region of subtilisin BPN 0 of wild-type-like subtilisin BPN 0 or
and mature region of subtilisin BPN 0 of propeptide-deleted subtilisin
the sequence between the signal peptide and propeptide of wild-type
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isin BPN 0 [19], POIA1cm is expected to exhibit a stronger
activity than the wild-type POIA1, when both function as
intramolecular chaperones.
The chimera protein in which wild-type POIA1 or POIA1cm
was fused to the N-terminus of subtilisin BPN 0 with a
Ser221ﬁ Cys substitution was shown to be expressed as an
inclusion body in E. coli. They were puriﬁed in the presence
of 6 M urea after the solubilization of the inclusion bodies in
6 M GdnHCl and dialysis. Pro-subtilisin BPN 0 with a
Ser221ﬁ Cys substitution was also puriﬁed in a similar way.
The puriﬁed proteins were adjusted to a concentration of
10 lM and then subjected to dialysis against a refolding buﬀer
containing 0.5 M (NH4)2SO4, 1 mM CaCl2 and 5 mM 2-
mercaptoethanol. After dialysis at 4 C for 2 days, proteins
in the dialysis apparatus were precipitated with trichloroacetic
acid and analyzed by SDS–PAGE.
As shown in Fig. 2, all the samples produce two bands that
correspond to processed species (subtilisin BPN 0 and wild-type
POIA1, POIA1cm or propeptide) in addition to unprocessed
species, indicating that wild-type POIA1 and POIA1cm can
function as intramolecular chaperones of subtilisin BPN 0, in
a similar way to the propeptide, although their activities diﬀers
in their extent. Among the samples, the diﬀerence in the total
amount of protein on the gel, in spite of the same amount
loaded, was considered to be related to the diﬀerences in the
amount of precipitate during dialysis. It was found that pro-
subtilisin hardly produced precipitates, but that approximately
one-half the amount of fused proteins with wild-type POIA1
or POIA1cm was precipitated during dialysis. Electrophoretic
analysis showed that the precipitates were mainly composed of
an unprocessed fused protein and subtilisin BPN 0, and that
their amount ratio was similar to that in soluble fractions (dataFig. 2. In vitro intramolecular chaperone activity of propeptide, wild-
type POIA1 or POIA1cm on the basis of occurrence of processing in
pro-subtilisin or chimera protein after refolding. Pro-subtilisin with a
Ser221ﬁ Cys substitution or chimera protein in which wild-type
POIA1 or POIA1cm was attached to the N-terminus of subtilisin BPN 0
with a Ser221ﬁ Cys substitution was puriﬁed in the presence of 6 M
urea and its concentration was adjusted to 10 lM. The protein solution
thus obtained was subjected to dialysis against 50 mM Tris–HCl/0.5 M
(NH4)2SO4/1 mM CaCl2/5 mM 2-mercaptoethanol (pH 7.0) at 4 C for
2 days. Proteins in an aliquot of 40 ll were precipitated by adding
trichloroacetic acid to a ﬁnal concentration of 20% and analyzed by
SDS–polyacrylamide gel electrophoresis.not shown). Since the precipitates formed during dialysis are
considered to be the results of misfolding, the amount of pro-
cessed subtilisin BPN 0 molecules after dialysis seems to be re-
lated to the intramolecular chaperone activity of the
propeptide or POIA1 in vitro.
The electrophoretic pattern in Fig. 2 shows that the amount
of subtilisin BPN 0 from pro-subtilisin was most abundant and
that the amount of subtilisin BPN 0 from the chimera protein
with wild-type POIA1 was considerably lower than other
two cases, indicating that wild-type POIA1 is a much less eﬀec-
tive intramolecular chaperone than POIA1cm or the propep-
tide, as expected. The fact that the chimera protein with
POIA1cm produced the aggregates after dialysis suggests that
POIA1cm is a less eﬀective intramolecular chaperone than the
propeptide, although the amount ratios of subtilisin BPN 0 to
unprocessed species in the soluble fraction are similar for the
propeptide and POIA1cm.
3.2. In vivo experiments: subtilisin production from chimera gene
of POIA1 and subtilisin BPN 0
In the in vitro experiments described above, the function of
POIA1 as an intramolecular chaperone was demonstrated on
the basis of the occurrence of autoprocessing in the chimera
protein of POIA1 and subtilisin BPN 0. We also examined the
function of POIA1 as an intramolecular chaperone in vivo.
The propeptide-encoding region of the subtilisin BPN 0 gene
was substituted with the wild-type POIA1 or POIA1cm gene,
and the chimera gene thus constructed was inserted into a
shuttle vector of E. coli and B. subtilis. After the transforma-
tion of B. subtilis, the secretory production of active and free
subtilisin BPN 0 molecules was examined on the basis of the
formation of halos on the skim milk plate. The original cleav-
age sequence between the signal peptide and the propeptide of
subtilisin BPN 0 was estimated to be Ala-Ala [25,26], whereas
the corresponding sequence of our constructs, Ala-Met. Since
cleavage by a signal peptidase was considered to depend on the
amino acid at the N-terminal side of the cleavage site, it
seemed that the eﬀect of our sequence on the secretory produc-
tion of active subtilisin BPN 0 was negligible.
As shown in Fig. 3A, a halo was formed around a Bacillus
colony transformed with a plasmid encoding a chimera gene
of subtilisin BPN 0 and wild-type POIA1 or POIA1cm. This re-
sult strongly suggests that both wild-type POIA1 and
POIA1cm can function as intramolecular chaperones neces-
sary for the correct folding of subtilisin BPN 0 to produce an
active species. As a control, when a plasmid encoding the sig-
nal peptide and the mature region of subtilisin BPN 0 but lack-
ing the propeptide region was introduced into Bacillus cells, a
halo was not observed around its colony. In contrast, a Bacil-
lus colony transformed with a plasmid encoding the wild-type-
like subtilisin BPN 0 gene was found to form a halo of a much
larger diameter than that in the case of a Bacillus colony trans-
formed with a chimera gene of POIA1 and subtilisin BPN 0, de-
spite the fact that in this construct of wild-type-like subtilisin
BPN 0, the junction sequence between the signal peptide and
the propeptide was changed from Ala-Ala to Ala-Met to intro-
duce the same junction sequence of the chimera gene of
POIA1cm and subtilisin BPN 0. Relative proteolytic activities
in the culture supernatants after 2 day-cultivation, which were
measured as rates of increasing absorbance at 410 nm by re-
lease of p-nitroaniline from a synthetic substrate, were 25, 1
and 0.27 for the Bacillus cells transformed with a plasmid
Fig. 3. (A) In vivo intramolecular chaperone activity of propeptide
wild-type POIA1 or POIA1cm detected on the basis of halo formation
around Bacillus cells. B. subtilis UOT0999 cells were transformed with
multimerized forms of the plasmid encoding the wild-type-like
subtilisin BPN 0 gene or chimera gene in which the propeptide region
was substituted with wild-type POIA1 or POIA1cm, and inoculated
onto an LB plate containing 1% skim milk and tetracyclin, and
incubated at 37 C for 39 h. (B) Electrophoretic analysis of proteins in
the culture supernatants of Bacillus cells transformed with a plasmid
encoding the propeptide, wild-type POIA1 or POIA1cm. After 2 day-
cultivation at 37 C, proteins in a 1 ml aliquot of 50 ml culture were
precipitated with trichloroacetic acid, and subjected to SDS–poly-
acrylamide gel electrophoresis. M, molecular weight markers.
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with POIA1cm and chimera protein with wild-type POIA1,
respectively.
The in vitro experiments indicated that POIA1cm is a much
more eﬀective intramolecular chaperone than wild-type
POIA1. However, a halo around a Bacillus colony transformed
with a plasmid encoding the chimera protein with POIA1cm is
slightly larger than those with a plasmid encoding the chimera
protein with wild-type POIA1. Such diﬀerence in halo diame-
ter was considered to be due to the diﬀerence in the numberof active subtilisin molecule. We previously demonstrated that
POIA1cm is a strong and resistant inhibitor of subtilisin BPN 0,
whereas wild-type POIA1 is a digestible inhibitor. Therefore,
the reason for the Bacillus colony transformed with a plasmid
with the POIA1cm gene forming a slightly larger halo than
that transformed with wild-type POIA1 gene was thought to
be the marked reduction in the number of active and free sub-
tilisin BPN 0 molecules after processing caused by the tight
binding of subtilisin BPN 0 to POIA1cm in spite of POIA1cm
being suﬃciently active to function as an intramolecular
chaperone.
With the above considerations, we also have carried out elec-
trophoretic analysis of proteins in the culture supernatants of
Bacillus cells cultivated for 2 days. As shown in Fig. 3B, the
Bacillus cells transformed with a plasmid encoding the wild-
type-like subtilisin BPN 0 gene produced a large amount of
subtilisin molecule, although a comparable amount of pro-
subtilisin molecule was also observed. The band of the propep-
tide was not detected as expected, due to its degradation by
active subtilisin molecules. In the culture supernatants of the
Bacillus cells transformed with a plasmid encoding POIA1cm,
a band corresponding to POIA1cm was detected in addition to
the bands of processed subtilisin BPN 0 and unprocessed chi-
mera protein. Therefore, the proteolytic activity of processed
subtilisin molecules was largely suppressed by binding with
POIA1cm which is a strong and resistant inhibitor of subtilisin
BPN 0. In contrast, the amount of subtilisin BPN 0 in the culture
supernatants of the Bacillus cells transformed with a plasmid
encoding wild-type POIA1 was very low, and the band of
POIA1 was hardly detected maybe due to its degradation by
subtilisin BPN 0, thus leading to the formation of only a small
halo on the skim milk plate.
These results by electrophoretic analysis are just consistent
with those by the in vitro experiments and inhibitory proper-
ties of the propeptide and POIA1, and can well explain the
diameter of halos on the skim milk plate and proteolytic activ-
ities in the culture supernatants.
3.3. Eﬀects of Pheﬁ Ala substitution at diﬀerent sites in POIA1
on its intramolecular chaperone activities in vitro and in vivo
The in vitro and in vivo experiments described above clearly
show that POIA1 can function as an intramolecular chaper-
one, although it was originally discovered as a protease inhib-
itor. In our previous studies on POIA1 as a protease inhibitor,
we found that a Pheﬁ Ala substitution at diﬀerent sites of
POIA1cm produces diﬀerent eﬀects on the POIA1 structure
and functions [27]. When Phe at position 56 of POIA1cm
was substituted with Ala, the resultant mutant of POIA1 tem-
porarily inhibited subtilisin BPN 0, in spite of the retention of
its tertiary structure as determined by CD spectral measure-
ments. In contrast, it was found that a Pheﬁ Ala substitution
at position 44 results in the loss of the POIA1 tertiary structure
and the conversion of POIA1 to a temporary inhibitor. We
therefore examined the eﬀects of these substitutions on the
intramolecular chaperone activity of POIA1, and investigated
its relation to the characteristics as a protease inhibitor and the
tertiary structure of POIA1.
Fig. 4 shows that a chimera protein of POIA1cm with a
Phe56ﬁ Ala substitution and subtilisin BPN 0 produced two
additional bands corresponding to processed species whose
amounts are comparable to that of POIA1cm; no bands cor-
responding to processed species are observed for a chimera
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subtilisin BPN 0. Similarly, Fig. 5A shows that the Bacillus
colony transformed with a chimera gene encoding POIA1cm
with a Phe56ﬁ Ala substitution and subtilisin BPN 0 formed
a much larger halo on the skim milk plate than that trans-
formed with POIA1cm. In contrast, no halo was formed
around the Bacillus colony transformed with a chimera gene
with a Phe44ﬁ Ala substitution in POIA1cm. Electropho-
retic pattern in Fig. 5B also shows that the band of processed
subtilisin BPN 0 was hardly detected in the culture superna-
tants of the Bacillus cells transformed with a chimera gene
encoding POIA1cm with a Phe44ﬁ Ala substitution,
whereas the Bacillus cells transformed with a chimera gene
with a Phe56ﬁ Ala substitution produced the band of active
and free subtilisin molecules. Relative proteolytic activities in
the culture supernatants measured as rates of increasing
absorbance at 410 nm by hydrolysis of a synthetic substrate
were 3.6, 1 and 0.04 for the Bacillus cells transformed with
a plasmid encoding chimera protein with POIA1cm with a
Phe56ﬁ Ala substitution, chimera protein with POIA1cm
and chimera protein with POIA1cm with a Phe44ﬁ Ala sub-
stitution, respectively.
These results clearly demonstrate that the intramolecular
activity of POIA1 is closely related to the tertiary structure
and inhibitory properties of POIA1. The Phe44ﬁ Ala mutant
of POIA1cm lacked an intramolecular chaperone activity; this
might have been due to the loss of its tertiary structure caused
by the substitution. The Phe56ﬁ Ala mutant of POIA1cm re-
tained its tertiary structure, as in the case of POIA1cm; this
might have led to its in vitro intramolecular chaperone activity
being similar to that of POIA1cm. Since a Phe56ﬁ Ala substi-
tution converts POIA1cm from a resistant inhibitor into a
digestible temporary inhibitor, the POIA1cm portion with a
Phe56ﬁ Ala substitution of a secreted chimera protein is de-
graded by an active species of subtilisin BPN 0 more easily than
POIA1cm, thus producing a larger halo on the skim milk plate.
Thus, the Phe56ﬁ Ala mutant of POIA1cm that possesses a
tertiary structure but has been converted into a digestible tem-
porary inhibitor is the most eﬀective intramolecular chaperoneFig. 4. In vitro intramolecular chaperone activity of POIA1cm, or its
Phe44ﬁ Ala or Phe56ﬁ Ala mutant on the basis of occurrence of
processing in chimera protein after refolding. Details are essentially the
same as those described in the legend of Fig. 2.
Fig. 5. (A) In vivo intramolecular chaperone activity of POIA1cm, or
its Phe44ﬁ Ala or Phe56ﬁ Ala mutant on the basis of halo
formation around Bacillus cells. (B) Electrophoretic analysis of
proteins in the culture supernatants of Bacillus cells transformed with
a plasmid encoding POIA1cm, or its Phe44ﬁ Ala or Phe56ﬁ Ala
mutant. Details are essentially the same as those described in the
legend of Fig. 3. M, molecular weight markers.to form a large halo among the POIA1 mutants examined in
this study, although its activity is still weaker than that of
the propeptide of subtilisin BPN 0.4. Discussion
Although POIA1 had been isolated as an endogenous inhib-
itor of P. ostreatus proteinase A [17], the fact that its amino
acid sequence is homologous to those of the propeptides of
subtilisin by about 30% prompted us to examine the possible
functional similarity between these proteins. In our previous
studies on POIA1, we have demonstrated that POIA1 is un-
ique among serine protease inhibitors, in that it utilizes its C-
terminal region for binding to and inhibiting subtilisin BPN 0
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Therefore, POIA1, which is a digestible temporary inhibitor
of subtilisin BPN 0, could be converted into a resistant and
strong inhibitor of subtilisin BPN 0 by substituting its C-termi-
nal six residues with those of the propeptide of subtilisin BPN 0.
In this study, we have shown that POIA1 can function as an
intramolecular chaperone of subtilisin BPN 0 in vitro and
in vivo using chimera genes with subtilisin BPN 0, in which
the propeptide-encoding region has been substituted with the
POIA1 gene.
In vitro experiments have shown that POIA1cm is a much
more eﬀective intramolecular chaperone of subtilisin BPN 0
than wild-type POIA1, suggesting that the tight binding of
POIA1cm with subtilisin BPN 0 as a result of the substitution
of its C-terminal six residues with those of the propeptide of
subtilisin BPN 0 is necessary for the eﬀective intramolecular
chaperone activity of POIA1. A similar close relationship be-
tween aﬃnity to subtilisin BPN 0 and intramolecular chaperone
activity for the propeptide of subtilisin BPN 0 was also demon-
strated by Bryan et al., although they have analyzed C-termi-
nal truncated mutants of the propeptide [28]. However, the
number of active subtilisin BPN 0 molecules determined from
the diameter of the halo formed on the skim milk plate as
in vivo intramolecular chaperone activity of POIA1cm was
found to be only slightly higher than that of the wild-type
POIA1 and much lower than that of the propeptide, appar-
ently. These diﬀerences between the results of in vitro and
in vivo experiments were considered to be due to the diﬀer-
ences between the inhibitory properties of these proteins. Since
POIA1cm is a resistant and strong inhibitor of subtilisin BPN 0
[19], its degradation by subtilisin BPN 0 proceeds very slowly
compared with that of wild-type POIA1 and the propeptide,
as shown by the electrophoretic analysis of proteins in the cul-
ture supernatants of the Bacillus cells, thus leading to the re-
lease of only a small number of active and free subtilisin
BPN 0 molecules. In contrast, the propeptide of subtilisin BPN 0
is a temporary inhibitor of subtilisin BPN 0 that is more rapidly
degraded by subtilisin BPN 0 [3,29] than POIA1cm, thus result-
ing in the formation of a large halo. Wild-type POIA1, which
is also a digestible temporary inhibitor of subtilisin BPN 0, was
found to be a much less eﬀective intramolecular chaperone of
subtilisin BPN 0 as determined in the same in vitro experiments
described above. Therefore, the Bacillus cell transformed with
a chimera gene of wild-type POIA1 and subtilisin BPN 0
showed the smallest halo among the cells transformed with
three genes.
Then, a question arises whether the tight binding to subtili-
sin BPN 0 is suﬃcient for the intramolecular chaperone activity
of POIA1. We previously demonstrated that a Pheﬁ Ala sub-
stitution at diﬀerent sites of POIA1cm converts POIA1cm into
a digestible temporary inhibitor, but produces diﬀerent eﬀects
on the POIA1 tertiary structure [27]. The Phe56ﬁ Ala substi-
tution in POIA1cm resulted in the maintenance of POIA1 ter-
tiary structure, whereas the Phe44ﬁ Ala substitution resulted
in the loss of such a tertiary structure, as determined by CD
spectral measurements. Therefore, we have examined the rela-
tionship between the tertiary structure and intramolecular
chaperone activity of POIA1. As shown by in vitro and
in vivo experiments, POIA1cm with a Phe44ﬁ Ala substitu-
tion could not function as an intramolecular chaperone of sub-
tilisin BPN 0, because processed species or halos on the skim
milk plate were hardly formed from the chimera protein andaround a Bacillus colony, respectively. Upon this substitution,
the ability of POIA1cm to bind to subtilisin BPN 0 was weak-
ened by about 80-fold, and this decrease in the extent of inter-
action was also considered to be the reason for the loss of the
intramolecular chaperone activity of the Phe44ﬁ Ala mutant
of POIA1cm. However, the amino acid sequence of the POIA1
C-terminal region, which is the main region responsible for
binding to subtilisin BPN 0, was the same as that of POIA1cm,
and the decrease in the extent of the interaction of this mutant
with subtilisin BPN 0 was thought to be due to the entropic ef-
fects caused by the loss of the POIA1 tertiary structure. There-
fore, we considered that the loss of the intramolecular
chaperone activity of the Phe44ﬁ Ala mutant of POIA1cm
is mainly due to the loss of its tertiary structure.
In a parallel study, we have determined the solution struc-
ture of POIA1 by NMR spectroscopy, and found that the
POIA1 tertiary structure is very similar to that of the propep-
tide of subtilisin BPN 0 in complex with a cognate protease [20],
in spite of a sequence homology of only approximately 30%.
Therefore, such a POIA1 tertiary structure seems to be an
inevitable requirement for the intramolecular chaperone activ-
ity of POIA1. This situation in POIA1, however, is somewhat
diﬀerent from that in the propeptide. The propeptide of subtil-
isin BPN 0 does not have a deﬁned tertiary structure in isolated
form, but it acquires a tertiary structure upon the formation of
a complex with a cognate protease [4–6]. Although the detailed
molecular mechanisms of such a phenomenon in the propep-
tide have not been clariﬁed yet, it is considered that similar
phenomena do not occur in the Phe44ﬁ Ala mutant of
POIA1cm, since this mutant could not function as an intramo-
lecular chaperone. However, our groups and others have dem-
onstrated that the formation of the tertiary structure of a
propeptide by mutation introduction has produced positive ef-
fects on the intramolecular chaperone activity of the propeptide
[10–15].
A comparison of the propeptide of subtilisin BPN 0, wild-
type POIA1, POIA1cm and its Phe44ﬁ Ala mutant has dem-
onstrated that the tertiary structure of POIA1 which is similar
to that of the propeptide of subtilisin BPN 0, is necessary for the
function of POIA1 as an intramolecular chaperone, and that
an increased ability to bind to subtilisin BPN 0 makes POIA1
a more eﬀective intramolecular chaperone of subtilisin BPN 0.
However, since POIA1cm is a resistant inhibitor of subtilisin
BPN 0, it could not be degraded by subtilisin BPN 0 after func-
tioning as an intramolecluar chaperone, thus leading to the
formation of a halo smaller than that obtained in the case of
the propeptide of subtilisin BPN 0. This is in marked contrast
to the case of the propeptide. Therefore, if a POIA1 mutant
that is digestible by subtilisin BPN 0 and retains its tertiary
structure could be generated, such a mutant would function
as an eﬀective intramolecular chaperone, which could produce
active and free subtilisin BPN 0 molecules. In our previous
study on POIA1, we have identiﬁed a Phe56ﬁ Ala substitu-
tion in POIA1 to be suitable for satisfying this criterion.
Fig. 4A shows that the Bacillus colony transformed with the
chimera gene in which a Phe56ﬁ Ala substitution was intro-
duced into the POIA1cm region exhibits a halo larger than
that in the case of the Bacillus colony transformed with the
POIA1cm gene.
In conclusion, we have demonstrated that POIA1, which had
been originally discovered as a protease inhibitor with a se-
quence homology of only approximately 30% to the propeptide
4436 S. Kojima et al. / FEBS Letters 579 (2005) 4430–4436of subtilisin BPN 0, can function as an intramolecular chaper-
one of subtilisin BPN 0, and that its activity is closely related
to its tertiary structure, which resembles that of the propeptide
in complex with subtilisin BPN 0, and its ability to bind to a
protease. We are currently investigating in more detail the
requirements of POIA1 for its function as an intramolecular
chaperone by analyzing other POIA1 mutants. Through such
studies, the molecular mechanisms of the propeptide-mediated
refolding of subtilisin BPN 0 will be clariﬁed from diﬀerent view-
points. In addition, some hints on the evolutional origin of the
propeptide may be provided in the future.
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